Clinical trial

Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies

NCT00805467

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2008-08-01

PhasePHASE2

Study timeline

Study start (unknown)2008-08-01Date precision: month

Registry last updated2014-06-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

Fostamatinib Disodium (R935788)DRUG

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

San AntonioTexas, United States1 San DiegoCalifornia, United States1 Washington D.C.District of Columbia, United States1 OrlandoFlorida, United States1 AustinTexas, United States1 OmahaNebraska, United States1 HamburgGermany1 La JollaCalifornia, United States1 BordeauxFrance1 GainesvilleFlorida, United States1 BucharestRomania1 KrakowPoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00805467 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.